Atlas Trials

Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults

Clinical trial NCT07688369 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07688369
Sponsor
Serum Institute of India Pvt. Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Polio Immunity
Start date
2026-07-01
Primary completion
2026-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.